CEV
CellaVision
Stock
Stock
ISIN: SE0000683484
Ticker: CEVI
SE0000683484
CEVI
Price
Price
CHART BY
Historical dividends and forecast
CellaVision has so far distributed $0.207 in 2024. The next dividend will be paid on 13.05.2025
$0.147
CHART BY
Frequently asked questions
What is CellaVision's market capitalization?
The market capitalization of CellaVision is $477.20M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is CellaVision's Price-to-Earnings (P/E) ratio?
The Price-to-Earnings (P/E) ratio (TTM) for CellaVision is 35.09. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
What is the Earnings Per Share (EPS) for CellaVision?
CellaVision's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $0.57. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for CellaVision's stock?
Currently, 3 analysts cover CellaVision's stock, with a consensus target price of $25.05. Analyst ratings provide insights into the stock's expected performance.
What is CellaVision's revenue over the trailing twelve months?
Over the trailing twelve months, CellaVision reported a revenue of $66.74M.
What is the EBITDA for CellaVision?
CellaVision's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $20.69M. EBITDA measures the company's overall financial performance.
What is the free cash flow of CellaVision?
CellaVision has a free cash flow of $19.26M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does CellaVision have, and what sector and industry does it belong to?
CellaVision employs approximately 228 people. It operates in the Health Care sector, specifically within the Medical Specialties industry.
What is the free float of CellaVision's shares?
The free float of CellaVision is 14.96M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- $477.20M
- EPS (TTM)
- $0.57
- Free Float
- 14.96M
- P/E ratio (TTM)
- 35.09
- Revenue (TTM)
- $66.74M
- EBITDA (TTM)
- $20.69M
- Free Cashflow (TTM)
- $19.26M
Pricing
- 1D span
- $19.66$20.11
- 52W span
- $17.64$29.64
Analyst Ratings
The price target is $25.05 and the stock is covered by 3 analysts.
Buy
1
Hold
2
Sell
0
Information
CellaVision AB engages in the provision of digital microscopy solutions for hematology laboratories. The firm's products include Analyzers, Instruments, DIFF-Line™ by CellaVision, Reagents, and Software and applications. It operates through the following geographical segments: Americas, APAC, and EMEA. The company was founded by Lars Christer Fedrik Fåhraeus on November 16, 1994 and is headquartered in Lund, Sweden.
- Employees
- 228
- Industries
- Medical Specialties
- Sector
- Health Care
Identifier
- ISIN
- SE0000683484
- Primary Ticker
- CEVI